0.0001
0.0000
(0.00%)
At close: November 18 at 3:00:00 PM EST
Breakdown
TTM
7/31/2022
7/31/2021
7/31/2020
Operating Expense
32,650.5120
37,012.0620
48,380.0580
43,409.0850
Operating Income
-32,650.5120
-37,012.0620
-48,380.0580
-43,409.0850
Net Non Operating Interest Income Expense
-52.1300
-20.9250
-15.8570
-5.1140
Other Income Expense
-17.3730
-480.7950
816.0010
288.1880
Pretax Income
-32,720.0150
-37,513.7820
-47,579.9140
-43,126.0110
Tax Provision
-3,334.1480
-3,334.1480
-2,412.1830
-872.5850
Net Income Common Stockholders
-29,385.8670
-34,179.6340
-45,167.7310
-42,253.4260
Diluted NI Available to Com Stockholders
-29,385.8670
-34,179.6340
-45,167.7310
-42,253.4260
Basic EPS
-14.91
-19.14
-30.14
-56.32
Diluted EPS
-14.91
-19.14
-30.14
-56.32
Basic Average Shares
1,989.0110
1,786.5570
1,495.6070
751.5700
Diluted Average Shares
1,989.0110
1,786.5570
1,495.6070
751.5700
Total Operating Income as Reported
-32,650.5120
-37,012.0620
-48,380.0580
-43,409.0850
Total Expenses
32,650.5120
37,012.0620
48,380.0580
43,409.0850
Net Income from Continuing & Discontinued Operation
-29,385.8670
-34,179.6340
-45,167.7310
-42,253.4260
Normalized Income
-29,319.1498
-33,715.2901
-45,943.0291
-42,354.4787
Interest Expense
52.1300
20.9250
15.8570
5.1140
Net Interest Income
-52.1300
-20.9250
-15.8570
-5.1140
EBIT
-32,667.8850
-37,492.8570
-47,564.0570
-43,120.8970
EBITDA
-31,732.4700
-36,426.5410
-46,485.8940
-42,130.6090
Reconciled Depreciation
935.4150
1,066.3160
1,078.1630
990.2880
Net Income from Continuing Operation Net Minority Interest
-29,385.8670
-34,179.6340
-45,167.7310
-42,253.4260
Total Unusual Items Excluding Goodwill
-74.2870
-509.6520
816.7050
103.1360
Total Unusual Items
-74.2870
-509.6520
816.7050
103.1360
Normalized EBITDA
-31,658.1830
-35,916.8890
-47,302.5990
-42,233.7450
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0000
Tax Effect of Unusual Items
-7.5698
-45.3081
41.4069
2.0833
7/31/2020 - 4/7/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
KLDO Kaleido Biosciences, Inc.
0.0001
0.00%
PRLD Prelude Therapeutics Incorporated
1.2150
+6.58%
PRAX Praxis Precision Medicines, Inc.
77.11
-0.63%
AIM AIM ImmunoTech Inc.
0.2141
-4.80%
JSPR Jasper Therapeutics, Inc.
5.70
-2.90%
XERS Xeris Biopharma Holdings, Inc.
3.4500
+1.17%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.8300
+7.02%
RIGL Rigel Pharmaceuticals, Inc.
22.17
+0.14%
CHRO Channel Therapeutics Corporation
2.4400
-12.54%
VIGL Vigil Neuroscience, Inc.
2.2000
-6.38%